Likewise, mice with complete genetic Stat3 ablation driven by the RosaCreERT2 promoter (RosaCreERT2;Stat3fl/fl) reached the experimental endpoint by day 4 (Supplementary Figure S4), indicating that the levels of cellular STAT3 activity inversely correlate with colitis severity. This evidence concerns the gene STAT3 and colitis.